$1800 | Single User
$2700 | Enterprise License

China Ginkgo Biloba Extract Industry Overview, 2017-2021
[Lowest Price Guaranteed: $1,800]

Published by CRI: 06 Sep 2016 | 40620 | In Stock
Related Topics: Engineering , Materials

Introduction

Description

Ginkgo biloba extract is rich in the extracted effective components with the ginkgo leaf as raw plus the suitable solvent. Various preparations whose raw material is GBE, are widely applied to such field as medicine, health products, food additive, functional beverage and cosmetics.

According to the statistics, the output volume of the global ginkgo biloba extracts was 526.3 tons in 2009, and that reached 158.4 tons in China which was the largest ginkgo biloba extract producer all over the world. Its production capacity accounted for over 50% of the global one. The output volume of ginkgo biloba extracts in Germany and France was about 110 tons.

In 2014, the output volume of global ginkgo biloba extracts reached 888.8 tons. In 2015, China exported plant extract products to over 130 countries and regions. The export value of traditional markets such as Asia, Europe and North America ranked top of the world, accounting for more than 90% of the total one.

Shanghai Sine Promod Pharmaceutical Co., Ltd. and Sinopec Shanghai Petrochemical Company Limited possess 6 related patents. Guizhou Biochemical Engineering Center and Zhejiang Conba Pharmaceutical Co., Ltd. have 5 related patents. Fudan University possesses 4 related patents.

CRI obtains the first hand information of China gingko biloba extract market through researches. It provides investors with the information concerning the market status, competition status and development trend of China ginkgo bioba extract industry through analyzing raw materials, production and demand of ginkgo bioba extracts so as to seize the investment opportunities.

Through this report, readers can acquire the following information:

-Development Environment of China Ginkgo Biloba Extract Industry

-Development Status of China Ginkgo Biloba Extract Industry

-Key Enterprises in China Ginkgo Biloba Extract Industry and Their Operation Status

-Market Competition of China Ginkgo Biloba Extract Industry

-Major Driving Forces and Market Opportunities in China Ginkgo Biloba Extract Industry

-Threats and Challenges Faced by China Ginkgo Biloba Extract Industry

-Price Trend of Raw Materials in China Ginkgo Biloba Extract Industry

-Development Trend of China Ginkgo Biloba Extract Industry, 2017-2021

Table of Contents
for China Ginkgo Biloba Extract Industry Overview, 2017-2021

  • Table of Contents

    1 Ginkgo Biloba Extract Industry Overview

    1.1 Relevant Concepts

    1.1.1 Definition

    1.1.2 Classification

    1.1.3 Analysis on Use

    1.2 Overview of Raw Material Market

    1.2.1 Analysis on Major Raw Material Origins

    1.2.2 Analysis on Supply and Demand Status of Raw Materials

    2 Overview of China Ginkgo Biloba Extract Market, 2011-2016

    2.1 Analysis on Supply of Ginkgo Biloba Extracts in China

    2.1.1 Overview of Production Status

    2.1.2 Analysis on Output Volume

    2.1.3 Analysis on Production Trend

    2.1.4 Analysis on Price Trend

    2.2 Analysis on Consumption of Ginkgo Biloba Extracts in China

    2.2.1 Analysis on Consumption Status

    2.2.2 Analysis on Domestic Consumption Scale

    2.2.3 Analysis on Consumption Trend

    2.3 Analysis on Import and Export of Ginkgo Biloba Extracts in China

    2.4 Competition Status of Ginkgo Biloba Extract Market

    2.4.1 Barriers to Entry

    2.4.2 Competition Structure of the Industry

    3 Analysis on Key Ginkgo Biloba Extract Enterprises in China, 2013-2016

    3.1 Enterprise 1

    3.1.1 Enterprise Profile

    3.1.2 Production Status of Ginkgo Biloba Extract

    3.2 Enterprise 2

    3.3 Enterprise 3

    3.4 Enterprise 4

    3.5 Enterprise 5

    4 Costs of Raw Materials and Prices of Products in China Ginkgo Biloba Extract Industry, 2013-2016

    4.1 Price Trend of Raw Materials of Ginkgo Biloba Extracts

    4.1.1 Price Trend of Gingko Leaf in China, 2013-2016

    4.1.2 Factors Influencing the Price Trend of Gingko Leaf

    4.2 Price Trend of Ginkgo Biloba Extract in China, 2013-2016

    5 Recommendations on Development and Investment in China Ginkgo Biloba Extract Market, 2017-2021

    5.1 Analysis on Factors Influencing the Development of China Ginkgo Biloba Extract Industry

    5.1.1 Driving Forces and Market Opportunities of China Ginkgo Biloba Extract Industry

    5.1.2 Threats and Challenges Faced by China Ginkgo Biloba Extract Industry

    5.2 Forecast on Supply and Demand of China Ginkgo Biloba Extract Industry

    5.3 Development Proposals

    Selected Charts

    Chart Definitions Related to Ginkgo Biloba Extract

    Chart Policies and Regulations Concerning Ginkgo Biloba Extract

    Chart Analysis on Major Application Areas of Ginkgo Biloba Extract

    Chart Analysis on Major Ginkgo Biloba Extract Origins in China

    Chart Output Volume of Gingko Leaf in China, 2011-2016

    Chart Output Volume of Ginkgo Biloba Extracts in China, 2011-2016

    Chart Sales Value of Ginkgo Biloba Extracts in China, 2011-2016

    Chart Analysis on Price Trend of Ginkgo Biloba Extract in China, 2013-2016

    Chart Price Trend of Ginkgo Biloba Extract in Chinese Market, 2013-2016

    Chart Forecast on Output Volume of Ginkgo Biloba Extracts in China, 2017-2021

Additional Details

Publisher

CRI

Publisher Information

CRI is a research and consulting company located in Shanghai, China, focusing on various industries and markets. It regularly produces a variety of market research reports, industry analytical reports publications covering 11 industries. It also provides customized industry research services for initial public offerings, corporate mergers and acquisitions, business development, market launch and financing for clients varying from private companies to the government entities. CRI has formed a series of methods and working ways in collecting data, analyzing facts & polices, establishing models and adapting the market.



Since 2007, CRI has established strategic cooperative relations with many institutions in the U.S.A., Canada, Australia, Hong Kong, etc. and gained abundant international resources as well as advanced research methods and strategic thinking.



Since 2008, CRI has integrated resources and begun providing investment consultation services for customers based on market research and oriented by international investment and domestic policies.



CRI also provides custom research. Since 2009, CRI has done more than 40 custom research projects serving IPO, corporate mergers and acquisition, business development, market launch, financing, etc. We provide flexible research services at reasonable cost. Our clients vary from private companies to governments.



CRI insists on the principles of independent research to win customers.



In the future, CRI will continue in-depth research on the development trends of Chinese market and even global market. CRI will provide services for customers adhering to the philosophy of high-efficiency, reliability, accuracy and concentration.

Reference

40620 | 1609410

Number of Pages

30

Report Format

PDF

CRI Reports

Related Reports

TitleDate PublishedPrice fromMore Details
China YCT International Group, Inc. (CYIG) - Financial and Strategic SWOT Analysis Review
SummaryChina YCT International Group Inc. (China YCT) is a pharmaceutical company. The company provi...
08 Nov 2015 by Global Data USD $300 More Info
China Biologic Products, Inc. (CBPO) - Financial and Strategic SWOT Analysis Review
SummaryChina Biologic Products, Inc. (CBP) is a plasma biopharmaceutical company that develops treat...
08 Nov 2015 by Global Data USD $300 More Info
China Resources Wandong Medical Equipment Co., Ltd. (600055) - Financial and Strategic SWOT Analysis Review
SummaryChina Resources Wandong Medical Equipment Co., Ltd. (CR Wandong), a subsidiary of Beijing Pha...
08 Nov 2015 by Global Data USD $300 More Info
China Grand Pharmaceutical and Healthcare Holdings Limited (512) - Financial and Strategic SWOT Analysis Review
SummaryChina Grand Pharmaceutical and Healthcare Holdings Limited (China Grand) is a pharmaceutical ...
08 Nov 2015 by Global Data USD $300 More Info
Anxin-China Holdings Limited (1149) - Financial and Strategic SWOT Analysis Review
SummaryAnxin-China Holdings Limited. (Anxin-China) is a safety solution providing company that focus...
08 Nov 2015 by Global Data USD $300 More Info
China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review
SummaryChina Medical System Holdings Limited (CMS) is a pharmaceutical service provider that include...
08 Nov 2015 by Global Data USD $300 More Info
China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic SWOT Analysis Review
SummaryChina Shineway Pharmaceutical Group Limited (China Shineway), a subsidiary of Shineway Pharma...
08 Nov 2015 by Global Data USD $300 More Info
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
08 Nov 2015 by Global Data USD $300 More Info
Inside China’s Pharma Sales Force – insights from the frontline
IntroductionIn 2011, China’s pharmaceutical sales force exceeded that of the U.S. for the first time...
01 Jul 2013 by FirstWord Pharma USD $695 More Info
Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma
IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
01 Jun 2012 by FirstWord Pharma USD $995 More Info

This report is published by CRI

CRI is a research and consulting company located in Shanghai, China, focusing on various industries and markets. It regularly produces a variety of market research reports, industry analytical reports publications covering 11 industries. It also provides customized industry research services for initial public offerings, corporate mergers and acquisitions, business development, market launch and financing for clients varying from private companies to the government entities. CRI has formed a series of methods and working ways in collecting data, analyzing facts & polices, establishing models and adapting the market.

Since 2007, CRI has established strategic cooperative relations with many institutions in the U.S.A., Canada, Australia, Hong Kong, etc. and gained abundant international resources as well as advanced research methods and strategic thinking.

Since 2008, CRI has integrated resources and begun providing investment consultation services for customers based on market research and oriented by international investment and domestic policies.

CRI also provides custom research. Since 2009, CRI has done more than 40 custom research projects serving IPO, corporate mergers and acquisition, business development, market launch, financing, etc. We provide flexible research services at reasonable cost. Our clients vary from private companies to governments.

CRI insists on the principles of independent research to win customers.

In the future, CRI will continue in-depth research on the development trends of Chinese market and even global market. CRI will provide services for customers adhering to the philosophy of high-efficiency, reliability, accuracy and concentration.

Download Free Report Summary PDF

China Ginkgo Biloba Extract Industry Overview, 2017-2021 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...